Every material Form 8-K abrdn Healthcare Investors filed with the SEC in 2023, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Deloitte & Touche LLP resigned on September 6, 2023 as independent auditor of the Tekla Healthcare Investors fund, citing an anticipated independence issue tied to a pending transaction between Tekla Capital Management and abrdn Inc. The fund's Board approved KPMG LLP as the new auditor on September 7, 2023, for the fiscal year ending September 30, 2023. The filing reports no adverse opinions, disagreements or reportable events with Deloitte.
Deloitte & Touche resigned on September 6, 2023, due to an anticipated independence issue linked to a pending Tekla Capital Management and abrdn Inc. transaction.
The Audit Committee approved the resignation on September 7, 2023.
KPMG LLP was engaged on September 7, 2023 for the fiscal year ending September 30, 2023.
Deloitte's prior reports for fiscal 2022 and 2021 contained no adverse opinion, disclaimer or qualification, and the filing reports no disagreements or reportable events.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every abrdn Healthcare Investors filing is on SEC EDGAR ↗. 8-K briefs of other companies →